Page 73 - AN-3-2

Advanced Neurology Inflammation in diabetic stroke: Treatment target

57. Fu Y, Zhang N, Ren L, et al. Impact of an immune modulator 67. Lok KZ, Basta M, Manzanero S, Arumugam TV.
fingolimod on acute ischemic stroke. Proc Natl Acad Sci U S Intravenous immunoglobulin (IVIg) dampens neuronal
A. 2014;111(51):18315-18320. toll-like receptor-mediated responses in ischemia.
doi: 10.1073/pnas.1416166111 J Neuroinflammation. 2015;12:73.
doi: 10.1186/s12974-015-0294-8
58. Veltkamp R, Gill D. Clinical trials of immunomodulation in
ischemic stroke. Neurotherapeutics. 2016;13(4):791-800. 68. Jin W, Wu Y, Chen N, et al. Early administration of MPC-
n(IVIg) selectively accumulates in ischemic areas to protect
doi: 10.1007/s13311-016-0458-y
inflammation-induced brain damage from ischemic stroke.
59. Yuan B, Meng X, Wang A, et al. Effect of different doses Theranostics. 2021;11(17):8197-8217.
of colchicine on high sensitivity C-reactive protein in
patients with acute minor stroke or transient ischemic doi: 10.7150/thno.58947
attack: A pilot randomized controlled trial. Eur J Pharm Sci. 69. Hong P, Li FX, Gu RN, et al. Inhibition of NLRP3
2022;178:106288. inflammasome ameliorates cerebral ischemia-reperfusion
doi: 10.1016/j.ejps.2022.106288 injury in diabetic mice. Neural Plast. 2018;2018:9163521.
60. Wang Y, Li J, Johnston SC, et al. Colchicine in High-risk doi: 10.1155/2018/9163521
patients with acute minor-to-moderate ischemic stroke 70. Hong P, Gu RN, Li FX, et al. NLRP3 inflammasome as a
or transient ischemic attack (CHANCE-3): Rationale and potential treatment in ischemic stroke concomitant with
design of a multicenter randomized placebo-controlled trial. diabetes. J Neuroinflammation. 2019;16(1):121.
Int J Stroke. 2023;18(7):873-878.
doi: 10.1186/s12974-019-1498-0
doi: 10.1177/17474930231172312
71. Ward R, Li W, Abdul Y, et al. NLRP3 inflammasome
61. Zhang YP, Cui QY, Zhang TM, et al. Chloroquine inhibition with MCC950 improves diabetes-mediated
pretreatment attenuates ischemia-reperfusion injury in the cognitive impairment and vasoneuronal remodeling after
brain of ob/ob diabetic mice as well as wildtype mice. Brain ischemia. Pharmacol Res. 2019;142:237-250.
Res. 2020;1726:146518.
doi: 10.1016/j.phrs.2019.01.035
doi: 10.1016/j.brainres.2019.146518
72. Zeng J, Wang Y, Luo Z, et al. TRIM9-mediated resolution of
62. Ruan C, Guo H, Gao J, et al. Neuroprotective effects of neuroinflammation confers neuroprotection upon ischemic
metformin on cerebral ischemia-reperfusion injury by stroke in mice. Cell Rep. 2019;27(2):549-560.e6.
regulating PI3K/Akt pathway. Brain Behav. 2021;11(10):e2335.
doi: 10.1016/j.celrep.2018.12.055
doi: 10.1002/brb3.2335
73. Nikolic D, Jankovic M, Petrovic B, Novakovic I. Genetic
63. Pawletko K, Jedrzejowska-Szypulka H, Bogus K, et al. aspects of inflammation and immune response in stroke. Int
After ischemic stroke, minocycline promotes a protective J Mol Sci. 2020;21(19):7409.
response in neurons via the RNA-binding protein HuR,
with a positive impact on motor performance. Int J Mol Sci. doi: 10.3390/ijms21197409
2023;24(11):9446. 74. Wang H, Li J, Zhang H, et al. Regulation of microglia
polarization after cerebral ischemia. Front Cell Neurosci.
doi: 10.3390/ijms24119446
2023;17:1182621.
64. Singhealth Foundation. Neuroprotection with Minocycline doi: 10.3389/fncel.2023.1182621
Therapy for Acute Stroke Recovery Trial (NeuMAST).
Bethesda, MD: National Library of Medicine (US); 75. Li L, Gan H, Jin H, et al. Astragaloside IV promotes
2000. Available from: https://clinicaltrials.gov/show/ microglia/macrophages M2 polarization and enhances
NCT00930020 [Last accessed on 2016 May 21]. neurogenesis and angiogenesis through PPARgamma
pathway after cerebral ischemia/reperfusion injury in rats.
65. Smith CJ, Hulme S, Vail A, et al. SCIL-STROKE
(Subcutaneous interleukin-1 receptor antagonist in ischemic Int Immunopharmacol. 2021;92:107335.
stroke): A randomized controlled phase 2 Trial. Stroke. doi: 10.1016/j.intimp.2020.107335
2018;49(5):1210-1216.
76. Cuartero MI, Ballesteros I, Moraga A, et al. N2 neutrophils,
doi: 10.1161/STROKEAHA.118.020750 novel players in brain inflammation after stroke: Modulation
by the PPARgamma agonist rosiglitazone. Stroke.
66. Strang AC, Bisoendial RJ, Kootte RS, et al. Pro-atherogenic
lipid changes and decreased hepatic LDL receptor expression 2013;44(12):3498-3508.
by tocilizumab in rheumatoid arthritis. Atherosclerosis. doi: 10.1161/STROKEAHA.113.002470
2013;229(1):174-181.
77. Tian X, Liu H, Xiang F, Xu L, Dong Z. -caryophyllene
doi: 10.1016/j.atherosclerosis.2013.04.031 protects against ischemic stroke by promoting polarization

Volume 3 Issue 2 (2024) 12 doi: 10.36922/an.1694